Klinische Forschung Hamburg

Hamburg 20253

6 studies enrolling now · 9 studies all time

What they study most

Alcohol Use Disorder, Anhedonia, Atherosclerotic Cardiovascular Disease (ASCVD), Depressive Disorder, Major, Diarrhea, Elevated Lp(a), Irritable Bowel Syndrome, Narcolepsy Type 1, Obesity, Osteoarthritis, Overweight

Studies at this site

• Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
• A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D) — Recruiting now
• A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee — Recruiting now
• A Study of Brenipatide in Participants With Alcohol Use Disorder — Recruiting now
• A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder — Recruiting now
• A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions — Recruiting now
• A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure — Stopped early
• A Study of TAK-861 in Participants With Narcolepsy Type 1 — Completed
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed